A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.
The current price of AstraZeneca PLC in the market is ¥27,787.07, with a 24-hour trading volume of ¥89.94B. The asset's market cap is ¥43.09T, after moving -3.85% in the last day.
Tokenized AstraZeneca PLC is trading at ¥16,102.38, with a tokenized market cap of ¥9.11B and a 24-hour trading volume of ¥126.83M. The tokenized asset has moved -0.95% in the past 24 hours.